QT Imaging Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
QT Imaging Holdings, Inc. (the "Company"), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on September 30, 2025. The filing details the entry into a Material Definitive Agreement for a private placement of securities, with the closing expected on October 3, 2025.
Key Financial Metrics and Transaction Details
The Company entered into a Securities Purchase Agreement for a private placement led by Sio Capital Management, LLC. The transaction structure and financial terms are as follows:
- Aggregate Gross Proceeds: Approximately $18,180,654.59.
- Securities Issued:
- 6,696,715 shares of Common Stock at $1.50 per share.
- 5,424,083 Pre-Funded Warrants at $1.4999 per warrant (exercisable for 1 share at $0.0001).
- Subscription Warrants to purchase up to 12,120,798 shares of Common Stock at $1.50 per share (5-year term, exercisable after 6 months).
- Placement Fees: 6.0% cash fee of gross proceeds payable to Ladenburg Thalmann & Co. Inc., plus reimbursement of up to $100,000 in expenses.
- Use of Proceeds: Working capital purposes. Proceeds are restricted from being used for stock redemptions, litigation settlements, or general debt repayment, with a specific exception for repaying $5 million of principal to Lynrock Lake Master Fund LP.
The filing does not provide current revenue, profit, cash flow, or margin data, as this is a transactional report rather than a periodic financial statement.
Material Changes and Agreements
The primary material change is the execution of the Securities Purchase Agreement and related documents:
- Registration Rights: The Company must file a registration statement for the resale of securities within 30 days of the agreement and have it declared effective within 90 days (or 120 days in case of a full SEC review).
- Liquidated Damages: If resales are prohibited for more than 10 consecutive days or 20 aggregate days in a 12-month period, the Company must pay 1% of the subscription amount monthly as liquidated damages.
- Listing Obligation: The Company must apply to list the Common Stock and Warrant Shares on a Nasdaq market within 30 days of closing.
Outlook, Risks, and Management Commentary
Management intends to use the net proceeds for working capital to support business operations. The filing includes extensive forward-looking statements regarding the commercialization of the QT Imaging Breast Acoustic CT Scanner and future business plans.
Key Risks Disclosed:
- Ability to sell and deploy the QT Imaging Breast Acoustic CT Scanner.
- Uncertainty in commercializing technology and moving product sales to production levels.
- Identified material weakness in internal controls over financial reporting.
- Ability to obtain future financing and meet debt obligations.
- Market competition and fluctuations in customer demand.
Investor Verification Checklist
- Verify the closing of the Private Placement on or around October 3, 2025, and the receipt of gross proceeds.
- Confirm the filing and effectiveness of the registration statement for the resale of securities within the 90-day window.
- Monitor the Company's application to list the new shares and warrant shares on a Nasdaq market.
- Review the status of the $5 million debt repayment to Lynrock Lake Master Fund LP.
- Assess progress on remediation of the material weakness in internal controls over financial reporting.